InvestorsHub Logo
Followers 8
Posts 1909
Boards Moderated 0
Alias Born 09/10/2012

Re: Frankestin post# 537

Tuesday, 02/28/2023 8:20:59 AM

Tuesday, February 28, 2023 8:20:59 AM

Post# of 561
GNI Group reported its Consolidated Financial Results for its Fiscal Year 2022 on February 15, 2023 showing continued revenue and profit growth from pirfenidone sales in China for the treatment of idiopathic pulmonary fibrosis, which includes revenue of approximately $102 million and net profit of approximately $23 million.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CBIO News